BATS BZX Real-Time Price
As of 12:47pm ET
| -0.0269 / -4.14%|
The 5 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 1.00, with a high estimate of 3.00 and a low estimate of 0.90. The median estimate represents a +60.51% increase from the last price of 0.62.
The current consensus among 5 polled investment analysts is to Hold stock in Anthera Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.